One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

Medically reviewed by William Truswell, MD Getting a plaque psoriasis diagnosis is straightforward. Your healthcare provider ...

Plaque psoriasis is characterized by raised ... plaques may appear salmon with silvery-white scale, or violet or dark brown with gray scale. Plaques can crop up on any area of the body but ...

Medically reviewed by Susan Bard, MD Psoriasis frequently appears on the arms, often on your elbow. Several types of ...

Research shows lifestyle changes like diet, exercise, and smoking cessation can assist with improving psoriasis outcomes and ...

A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.

The efficacy and safety of risankizumab remains similar across racial and ethnic groups of patients with moderate to severe plaque psoriasis.

First-of-its-kind Phase 3b study shows TREMFYA ® achieved statistical significance across all primary and secondary endpoints in low body surface area psoriasis with special site involvement ...

moderate plaque psoriasis (PsO) with special site involvement who had failed topical treatment. Data from the Phase 3b SPECTREM study to measure skin clearance and other treatment outcomes in low ...

Patients with plaque psoriasis treated with Johnson & Johnson’s oral IL-23 inhibitor JNJ-2113 have been shown to maintain skin clearance for up to a year, pointing to a durable effect for a drug ...